9th Fragment-based Drug Discovery Meeting (Booth 4)
Join WuXi AppTec at the 9th RSC-BMCS Fragment-based Drug Discovery meeting, which will focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programs. This agenda will be complemented by technology progress updates in high concentration, NMR, SPR and X-ray screening.
We are proud to be presenting a poster (P24) entitled "Covalent fragment-based drug discovery workflow demonstrated on Bruton’s Tyrosine Kinase". Request a meeting by completing the brief form on the right.